First Trust Advisors LP Has $69.20 Million Holdings in Intuitive Surgical, Inc. $ISRG

First Trust Advisors LP decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 154,731 shares of the medical equipment provider’s stock after selling 30,152 shares during the period. First Trust Advisors LP’s holdings in Intuitive Surgical were worth $69,200,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC lifted its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after buying an additional 731 shares during the period. Sivia Capital Partners LLC increased its stake in shares of Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares during the period. Schnieders Capital Management LLC. raised its position in shares of Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after acquiring an additional 268 shares during the last quarter. Fidelis Capital Partners LLC raised its position in shares of Intuitive Surgical by 3.2% during the second quarter. Fidelis Capital Partners LLC now owns 2,455 shares of the medical equipment provider’s stock worth $1,334,000 after acquiring an additional 75 shares during the last quarter. Finally, Illinois Municipal Retirement Fund lifted its stake in shares of Intuitive Surgical by 8.8% in the second quarter. Illinois Municipal Retirement Fund now owns 11,933 shares of the medical equipment provider’s stock worth $6,485,000 after acquiring an additional 968 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $485.85 on Wednesday. The company has a market cap of $172.54 billion, a P/E ratio of 61.58, a PEG ratio of 3.81 and a beta of 1.66. The stock has a 50 day simple moving average of $518.26 and a two-hundred day simple moving average of $512.74. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the prior year, the business earned $2.21 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. UBS Group set a $570.00 target price on Intuitive Surgical and gave the company a “neutral” rating in a report on Tuesday, February 24th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. HSBC upped their price objective on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. Royal Bank Of Canada increased their price objective on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 17th. Finally, Truist Financial lifted their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $615.86.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total transaction of $2,463,120.00. Following the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares of the company’s stock, valued at $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 37,802 shares of company stock worth $19,945,322 in the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.